GNbAC1
MS Patient, Ph.D.: The Diagnostic Saga of PPMS—A Tale of Seven Neurologists
How can so many people trained in the same profession reach such totally variable conclusions?
I’ve seen no fewer than seven neurologists in the past 6 years, often for...
People
Complementary/Alternative Medicine Use Changes With MS Progression
The transition from moderate to severe impairment is when many MS patients turn to complementary or alternative medicine
Persons with MS use complementary and alternative medicine most often during...
Clinical Research
Editors' Pick
American Society for Neurochemistry 2014
The American Society for Neurochemistry is meeting in Long Beach, California, 8-12 March 2014. Multiple Sclerosis Discovery Forum staffer Carol Cruzan Morton will be live tweeting from the event. Follow her tweets here or at @MSDForum.
Clinical Research, Drug Development, Laboratory Research, Meetings
MS Trial Alert: Investigators Recruiting 250 People with Primary- or Secondary-Progressive MS for Study of Oral Ibudilast
MS Trial Alert: Investigators Recruiting 250 People with Primary- or Secondary-Progressive MS for Study of Oral Ibudilast
March 3, 2014
Papers: 28 Feb 2014 - 7 Mar 2014
Postdoctoral Fellow -- Pharmacoepidemiology in Multiple Sclerosis Research Group
The University of British Columbia
Vancouver, BC, Canada
Posted:
6 Mar 2014
Autologous Stem Cell Transplant Effective in Inflammatory RRMS; Mechanism Emerging
Rebooting the immune system with a transplant of a patient’s own hematopoietic stem cells vanquishes MS symptoms. Understanding how it works may lead to development of safer alternatives.
Purging the immune system of myelin-reactive T cells and replacing them from an immune system...
Clinical Research
Pages
